Decentralized trials

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

From pre-market trials to post-market observational studies, hear from industry experts as they review three different case studies and discuss overcoming the challenges faced by medical device manufacturers today.

Participating in a decentralized clinical trial (DCT) can be a daunting experience from the patients’ perspective. Fortunately, technology platforms are evolving to give patients a greater sense of confidence than previously imaginable.

Listen in as leaders from Castor, Link2Trials, and Essity discuss how leveraging the right technology and partnerships can streamline your patient recruitment.

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

Join leaders from Trialbee and Castor as they discuss best practices for patient enrollment in decentralized clinical trials.

The need for findable, accessible, interoperable, and reusable clinical research data is growing. Learn more in this white paper from Castor

The benefits of integrating EHR data with an EDC range from reducing duplicate documentation and errors to enriching the clinical dataset with real-world data. Why aren’t more people doing it?

Leaders from Castor discuss what changes we can expect in clinical research, technology, and data through the lens of three key pillars

Each rare disease research breakthrough offers the promise of a longer, better life for patients who otherwise may…